Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,058,988 papers from all fields of science
Search
Sign In
Create Free Account
MD4
Known as:
MD4 hash
The MD4 Message-Digest Algorithm is a cryptographic hash function developed by Ronald Rivest in 1990. The digest length is 128 bits. The algorithm…
Expand
Wikipedia
(opens in a new tab)
Create Alert
Alert
Related topics
Related topics
36 relations
Cain and Abel
Collision attack
Comparison of cryptographic hash functions
Comparison of operating system kernels
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Long-term follow-up of the PI3K{delta} inhibitor TGR-1202 to demonstrate a differentiated safety profile and high response rates in CLL and NHL: Integrated-analysis of TGR-1202 monotherapy and…
H. Burris
,
I. Flinn
,
+17 authors
O. O’Connor
2016
Corpus ID: 79261844
7512Background: TGR-1202 is a novel, once-daily PI3Kδ inhibitor with a differentiated safety profile from other PI3Kδ inhibitors…
Expand
2015
2015
Clinical activity and safety profile of TGR-1202, a novel once daily PI3Kδ inhibitor, in patients with CLL and B-cell lymphoma.
H. Burris
,
M. Patel
,
+10 authors
I. Flinn
2015
Corpus ID: 79251594
7069 Background: TGR-1202 is a novel, next generation PI3Kδ inhibitor which lacks the hepatotoxicity associated with other PI3K…
Expand
Review
2015
Review
2015
Ibrutinib Versus Ofatumumab in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Results From the Randomized Phase III RESONATE™ (PCYC-1112) Trial
Jennifer R. Brown
,
J. Byrd
,
+17 authors
P. Hillmen
2015
Corpus ID: 74295456
2014
2014
TGR-1202, a Novel Once Daily PI3Kδ Inhibitor, Demonstrates Clinical Activity with a Favorable Safety Profile, Lacking Hepatotoxicity, in Patients with Chronic Lymphocytic Leukemia and B-Cell Lymphoma
H. Burris
,
M. Patel
,
+10 authors
I. Flinn
2014
Corpus ID: 79362321
Background: TGR-1202 is a novel oral, next generation PI3Kδ inhibitor which notably lacks the hepatotoxicity associated with…
Expand
2014
2014
Pracinostat in Combination with Azacitidine Produces a High Rate and Rapid Onset of Disease Remission in Patients with Previously Untreated Acute Myeloid Leukemia (AML)
G. Garcia-Manero
,
E. Atallah
,
+5 authors
S. Khaled
2014
Corpus ID: 68291484
Background: Pracinostat is a potent oral inhibitor of histone deacetylases (HDAC’s), selective for class I, II and IV isoforms…
Expand
2009
2009
Cryptanalysis on HMAC/NMAC-MD5 and MD5-MAC
Xiaoyun Wang
,
Hongbo Yu
,
Wei Wang
,
Haina Zhang
,
T. Zhan
International Conference on the Theory and…
2009
Corpus ID: 9587740
In this paper, we present the first distinguishing attack on HMAC and NMAC based on MD5 without related keys, which distinguishes…
Expand
2009
2009
The use of the RAFT-technique for the preparation of temperature/pH sensitive polymers in different architectures
Á. Licea-Claveríe
,
J. Álvarez-Sánchez
,
+5 authors
C. Frank
2009
Corpus ID: 20862823
In this contribution we report the use of the RAFT-technique for the preparation of three types of responsive polymeric materials…
Expand
Highly Cited
2002
Highly Cited
2002
A hardware implementation of MD4-family hash algorithms
Sandra Dominikus
International Conference on Electronics, Circuits…
2002
Corpus ID: 60941476
This article presents the design of an integrated circuit which is able to perform various different hash algorithms of the MD4…
Expand
2000
2000
Kerberos Interoperability Issues
Paul B. Hill
Large Installation System Administration of…
2000
Corpus ID: 12080387
MIT's computing environment is a heterogeneous environment that has used Kerberos as a primary authentication method for over a…
Expand
1997
1997
Digital signature for Diffie-Hellman public keys without using a one-way function
L. Harn
1997
Corpus ID: 35844584
The author proposes digital signature schemes without using a one-way function to sign Diffie-Hellman public keys. The advantage…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE